Koers Steris PLC Nyse
Aandelen
GB00BVVBC028
Medische apparatuur, benodigdheden & distributie
Omzet 2024 | 5,5 mld. 5,11 mld. | Omzet 2025 * | 5,58 mld. 5,18 mld. | Marktkapitalisatie | 22,86 mld. 21,23 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 378 mln. 351 mln. | Nettowinst (verlies) 2025 * | 684 mln. 635 mln. | EV/omzet 2024 | 4,04 x |
Nettoschuld 2024 * | 2,94 mld. 2,73 mld. | Nettoschuld 2025 * | 2,46 mld. 2,29 mld. | EV/omzet 2025 * | 4,54 x |
K/w-verhouding 2024 |
59
x | K/w-verhouding 2025 * |
32,8
x | Werknemers | - |
Dividendrendement 2024 * |
0,88% | Dividendrendement 2025 * |
0,96% | Vrij verhandelbaar | 99,73% |
Recentste transcriptie over Steris PLC
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Carestio
CEO | Chief Executive Officer | 51 | 01-08-18 |
Michael Tokich
DFI | Director of Finance/CFO | 56 | 01-02-14 |
Julie Winter
IRC | Investor Relations Contact | - | 01-05-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Breeden
BRD | Director/Board Member | 74 | 01-04-08 |
Director/Board Member | 74 | 01-10-03 | |
Director/Board Member | 58 | 28-07-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,84% | 182 mld. | |
+0,56% | 110 mld. | |
-3,35% | 68,11 mld. | |
+2,39% | 50,53 mld. | |
+9,36% | 44,8 mld. | |
+2,70% | 40,7 mld. | |
+3,43% | 26,53 mld. | |
+13,67% | 25,02 mld. | |
-0,32% | 24,96 mld. |